Report cover image

Global Antibiotics and Antimycotics Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 196 Pages
SKU # APRC20278578

Description

Summary

According to APO Research, The global Antibiotics and Antimycotics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antibiotics and Antimycotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antibiotics and Antimycotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Antibiotics and Antimycotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Antibiotics and Antimycotics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antibiotics and Antimycotics include Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Pfizer, GSK, Bayer and AbbVie, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antibiotics and Antimycotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Antibiotics and Antimycotics, also provides the sales of main regions and countries. Of the upcoming market potential for Antibiotics and Antimycotics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibiotics and Antimycotics sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Antibiotics and Antimycotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Antibiotics and Antimycotics sales, projected growth trends, production technology, application and end-user industry.

Antibiotics and Antimycotics Segment by Company

Sanofi
Johnson & Johnson
Novartis
Merck
Roche
Pfizer
GSK
Bayer
AbbVie
AstraZeneca
Eli Lilly
Antibiotics and Antimycotics Segment by Type

Aminoglycosides
Macrolides
Sulfonamides
Quinolones (Fluoroquinolones)
Penicillins
Tetracyclines
Carbapenems
Cephalosporins
Other
Antibiotics and Antimycotics Segment by Application

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Antibiotics and Antimycotics Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Colombia
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotics and Antimycotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibiotics and Antimycotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotics and Antimycotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antibiotics and Antimycotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibiotics and Antimycotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antibiotics and Antimycotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Antibiotics and Antimycotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Antibiotics and Antimycotics Market Size, 2020 VS 2024 VS 2031
1.3 Global Antibiotics and Antimycotics Market Size Estimates and Forecasts (2020-2031)
1.4 Global Antibiotics and Antimycotics Sales Estimates and Forecasts (2020-2031)
1.5 Global Antibiotics and Antimycotics Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Antibiotics and Antimycotics Market Dynamics
2.1 Antibiotics and Antimycotics Industry Trends
2.2 Antibiotics and Antimycotics Industry Drivers
2.3 Antibiotics and Antimycotics Industry Opportunities and Challenges
2.4 Antibiotics and Antimycotics Industry Restraints
3 Antibiotics and Antimycotics Market by Manufacturers
3.1 Global Antibiotics and Antimycotics Revenue by Manufacturers (2020-2025)
3.2 Global Antibiotics and Antimycotics Sales by Manufacturers (2020-2025)
3.3 Global Antibiotics and Antimycotics Average Sales Price by Manufacturers (2020-2025)
3.4 Global Antibiotics and Antimycotics Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Antibiotics and Antimycotics Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Antibiotics and Antimycotics Manufacturers, Product Type & Application
3.7 Global Antibiotics and Antimycotics Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Antibiotics and Antimycotics Market CR5 and HHI
3.8.2 Global Top 5 and 10 Antibiotics and Antimycotics Players Market Share by Revenue in 2024
3.8.3 2024 Antibiotics and Antimycotics Tier 1, Tier 2, and Tier 3
4 Antibiotics and Antimycotics Market by Type
4.1 Antibiotics and Antimycotics Type Introduction
4.1.1 Aminoglycosides
4.1.2 Macrolides
4.1.3 Sulfonamides
4.1.4 Quinolones (Fluoroquinolones)
4.1.5 Penicillins
4.1.6 Tetracyclines
4.1.7 Carbapenems
4.1.8 Cephalosporins
4.1.9 Other
4.2 Global Antibiotics and Antimycotics Sales by Type
4.2.1 Global Antibiotics and Antimycotics Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Antibiotics and Antimycotics Sales by Type (2020-2031)
4.2.3 Global Antibiotics and Antimycotics Sales Market Share by Type (2020-2031)
4.3 Global Antibiotics and Antimycotics Revenue by Type
4.3.1 Global Antibiotics and Antimycotics Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Antibiotics and Antimycotics Revenue by Type (2020-2031)
4.3.3 Global Antibiotics and Antimycotics Revenue Market Share by Type (2020-2031)
5 Antibiotics and Antimycotics Market by Application
5.1 Antibiotics and Antimycotics Application Introduction
5.1.1 Hospital Pharmacy
5.1.2 Online Pharmacy
5.1.3 Retail Pharmacy
5.2 Global Antibiotics and Antimycotics Sales by Application
5.2.1 Global Antibiotics and Antimycotics Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Antibiotics and Antimycotics Sales by Application (2020-2031)
5.2.3 Global Antibiotics and Antimycotics Sales Market Share by Application (2020-2031)
5.3 Global Antibiotics and Antimycotics Revenue by Application
5.3.1 Global Antibiotics and Antimycotics Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Antibiotics and Antimycotics Revenue by Application (2020-2031)
5.3.3 Global Antibiotics and Antimycotics Revenue Market Share by Application (2020-2031)
6 Global Antibiotics and Antimycotics Sales by Region
6.1 Global Antibiotics and Antimycotics Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Antibiotics and Antimycotics Sales by Region (2020-2031)
6.2.1 Global Antibiotics and Antimycotics Sales by Region (2020-2025)
6.2.2 Global Antibiotics and Antimycotics Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Antibiotics and Antimycotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Antibiotics and Antimycotics Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Antibiotics and Antimycotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Antibiotics and Antimycotics Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Antibiotics and Antimycotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Antibiotics and Antimycotics Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Antibiotics and Antimycotics Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Antibiotics and Antimycotics Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Antibiotics and Antimycotics Revenue by Region
7.1 Global Antibiotics and Antimycotics Revenue by Region
7.1.1 Global Antibiotics and Antimycotics Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Antibiotics and Antimycotics Revenue by Region (2020-2025)
7.1.3 Global Antibiotics and Antimycotics Revenue by Region (2026-2031)
7.1.4 Global Antibiotics and Antimycotics Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Antibiotics and Antimycotics Revenue (2020-2031)
7.2.2 North America Antibiotics and Antimycotics Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Antibiotics and Antimycotics Revenue (2020-2031)
7.3.2 Europe Antibiotics and Antimycotics Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Antibiotics and Antimycotics Revenue (2020-2031)
7.4.2 Asia-Pacific Antibiotics and Antimycotics Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Antibiotics and Antimycotics Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Antibiotics and Antimycotics Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Sanofi
8.1.1 Sanofi Comapny Information
8.1.2 Sanofi Business Overview
8.1.3 Sanofi Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Sanofi Antibiotics and Antimycotics Product Portfolio
8.1.5 Sanofi Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Johnson & Johnson Antibiotics and Antimycotics Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Novartis
8.3.1 Novartis Comapny Information
8.3.2 Novartis Business Overview
8.3.3 Novartis Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Novartis Antibiotics and Antimycotics Product Portfolio
8.3.5 Novartis Recent Developments
8.4 Merck
8.4.1 Merck Comapny Information
8.4.2 Merck Business Overview
8.4.3 Merck Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Merck Antibiotics and Antimycotics Product Portfolio
8.4.5 Merck Recent Developments
8.5 Roche
8.5.1 Roche Comapny Information
8.5.2 Roche Business Overview
8.5.3 Roche Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Roche Antibiotics and Antimycotics Product Portfolio
8.5.5 Roche Recent Developments
8.6 Pfizer
8.6.1 Pfizer Comapny Information
8.6.2 Pfizer Business Overview
8.6.3 Pfizer Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Pfizer Antibiotics and Antimycotics Product Portfolio
8.6.5 Pfizer Recent Developments
8.7 GSK
8.7.1 GSK Comapny Information
8.7.2 GSK Business Overview
8.7.3 GSK Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 GSK Antibiotics and Antimycotics Product Portfolio
8.7.5 GSK Recent Developments
8.8 Bayer
8.8.1 Bayer Comapny Information
8.8.2 Bayer Business Overview
8.8.3 Bayer Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Bayer Antibiotics and Antimycotics Product Portfolio
8.8.5 Bayer Recent Developments
8.9 AbbVie
8.9.1 AbbVie Comapny Information
8.9.2 AbbVie Business Overview
8.9.3 AbbVie Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 AbbVie Antibiotics and Antimycotics Product Portfolio
8.9.5 AbbVie Recent Developments
8.10 AstraZeneca
8.10.1 AstraZeneca Comapny Information
8.10.2 AstraZeneca Business Overview
8.10.3 AstraZeneca Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 AstraZeneca Antibiotics and Antimycotics Product Portfolio
8.10.5 AstraZeneca Recent Developments
8.11 Eli Lilly
8.11.1 Eli Lilly Comapny Information
8.11.2 Eli Lilly Business Overview
8.11.3 Eli Lilly Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Eli Lilly Antibiotics and Antimycotics Product Portfolio
8.11.5 Eli Lilly Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Antibiotics and Antimycotics Value Chain Analysis
9.1.1 Antibiotics and Antimycotics Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Antibiotics and Antimycotics Production Mode & Process
9.2 Antibiotics and Antimycotics Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Antibiotics and Antimycotics Distributors
9.2.3 Antibiotics and Antimycotics Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.